ESBL-production in Escherichia coli and Klebsiella pneumoniae isolates from Nigeria

被引：10
|
作者：
Hertz, Frederik B. [1 ,2 ]
Jansaker, Fillip [1 ]
Okon, Kenneth O. [3 ]
Abdulmumin, Ibrahim S. [6 ]
Onah, Joseph O. [4 ]
Ladan, Joshua [5 ]
Knudsen, Jenny D. [1 ]
机构：
[1] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, Hvidovre, Denmark
[2] Statens Serum Inst, Dept Virus & Microbiol Special Diagnost, Copenhagen, Denmark
[3] Fed Med Ctr, Dept Med Microbiol, Makurdi, Nigeria
[4] Clinton Hlth Access Initiat, Abuja, Nigeria
[5] Natl Primary Hlth Care Dev Agcy, Dept Dis & Immunizat, Abuja, Nigeria
[6] Abubakar Tafawa Balewa Univ Teaching Hosp, Dept Med Microbiol, Bauchi, Nigeria
来源：
MICROBIOLOGYOPEN | 2019年 / 8卷 / 09期
关键词：
Enterobacteriaceae; ESBL; Escherichia coli; Klebsiella pneumoniae; Nigeria;
D O I：
10.1002/mbo3.816
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The worldwide increase in infections caused by extended-spectrum beta-lactamase- (ESBL) and AmpC-producing Enterobacteriaceae (ESBL-E) is a concern. Surveillance is extensive in Europe, North America, and Asia. Yet, there is no summarizing surveillance in Africa. This study aimed to perform a preliminary investigation on the prevalence of ESBL-E in the northeastern part of Nigeria. However, of the 60 samples collected, we were able to culture 15 Escherichia coli and 7 Klebsiella spp. only. In the collection of clinical hospital samples, we found eight of 15 E. coli isolates to be ESBL (53%) and two out of seven Klebsiella spp. to be ESBL/AmpC (29%). Due to the limitations of this study, our findings cannot take a broad view on the prevalence of ESBL-E, in Nigeria and other parts of Africa. Yet, to know which genes encode ESBL in Nigeria, and to know exact prevalence of every ESBL gene would be of importance.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae
    Bitsori, Maria
    Galanakis, Emmanouil
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (12) : E332 - E335
  • [32] Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)
    Diestra, Karol
    Coque, Teresa M.
    Miro, Elisenda
    Oteo, Jesus
    Nicolau, Carlos Juan
    Campos, Jose
    Moya, Bartolome
    Curiao, Tania
    Perez-Vazquez, Maria
    Canton, Rafael
    Oliver, Antonio
    Navarro, Ferran
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 (07): : 404 - 410
  • [33] Phenotypic and molecular characterization of ESBL producing Escherichia coli and Klebsiella pneumoniae among Lebanese patients
    El-Hariri, Saria A.
    Saleh, Fatima
    Moghnieh, Wafaa
    Sokhn, Elie S.
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (03):
  • [34] Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates
    Yuan, Jinyi
    Xu, Xiaogang
    Guo, Qinglan
    Zhao, Xu
    Ye, Xinyu
    Guo, Yan
    Wang, Minggui
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (07) : 1655 - 1659
  • [35] Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae
    Alvarez-Uria, Gerardo
    Gandra, Sumanth
    Mandal, Siddhartha
    Laxminarayan, Ramanan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 68 : 50 - 53
  • [36] TRANSFERABLE RESISTANCE TO CEFTAZIDIME IN CLINICAL ISOLATES OF KLEBSIELLA PNEUMONIAE AND ESCHERICHIA-COLI
    VERSCHRAEGEN, G
    VUYE, A
    CLAEYS, G
    ACTA CLINICA BELGICA, 1988, 43 (05): : 356 - 361
  • [37] Comparison of Commensal and Clinical Isolates for Diversity of Plasmids in Escherichia coli and Klebsiella pneumoniae
    Rodriguez-Navarro, Judith
    Miro, Elisenda
    Brown-Jaque, Maryury
    Carlos Hurtado, Juan
    Moreno, Albert
    Muniesa, Maite
    Jose Gonzalez-Lopez, Juan
    Vila, Jordi
    Espinal, Paula
    Navarro, Ferran
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
  • [38] Correlation of RAPD-PCR Profiles with ESBL Production in Clinical Isolates of Klebsiella pneumoniae in Tehran
    Effekhar, Fereshteh
    Nourp, Parvaneh
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (01) : DC1 - DC3
  • [39] Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016
    Denisuik, Andrew J.
    Karlowsky, James A.
    Adam, Heather J.
    Baxter, Melanie R.
    Lagace-Wiens, Philippe R. S.
    Mulvey, Michael R.
    Hoban, Daryl J.
    Zhanel, George G.
    Nichol, Kimberly A.
    Walkty, Andrew
    Blondeau, J.
    Slinger, R.
    Davidson, R.
    Zhanel, G.
    Hoban, D.
    Delport, J.
    Ellis, C.
    Laverdiere, M.
    Loo, V
    Poutanen, S.
    Fuller, J.
    Roscoe, D.
    Desjardins, M.
    Matukas, L.
    Goyette, M.
    Lee, C.
    Carignan, A.
    Bergevin, M.
    Pelletier, R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 : 64 - 71
  • [40] Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019
    Karlowsky, James A.
    Lob, Sibylle H.
    DeRyke, C. Andrew
    Siddiqui, Fakhar
    Young, Katherine
    Motyl, Mary R.
    Sahm, Daniel F.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (03)
12345